JD Supra13d
Biologics and Biosimilars Landscape 2024: IP, Policy, and Market Developments
Last year marked an all-time record of 18 Food and Drug Administration (FDA) biosimilar approvals, bringing the total number ...
Business Wire14d
Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes
The pump and Control-IQ+ are indicated for use with NovoLog or Humalog U-100 insulin. t:slim X2 insulin pump: The pump is intended for the subcutaneous delivery of insulin, at set and variable rates, ...
thelistwire.usatoday15d
100 largest U.S. cities by population entering 2025
Sign up for our newsletter to get updates to your inbox, and also receive offers from us, our affiliates and partners. By signing up you agree to our Privacy Policy ...
Guyana Chronicle16d
GCA Mayor’s Cup 100 Overs U-17 tournament
Lomar Seecharran scored 90 and Munish Outar grabbed 5-25 to highlight the third round of the GCA Mayor’s Cup 100 Overs U-17 tournament yesterday. At the Transport Sport Club (TSC) Apple followed up ...
Renal & Urology News18d
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
Merilog administered subcutaneously 5 to 10 minutes before mealtime helps improve glycemic control. (HealthDay News) — The US Food and Drug Administration has approved Merilog (insulin-aspart ...
WebMD19d
FDA OKs First Fast-Acting Insulin Biosimilar for Diabetes
Merilog, made by Sanofi-Aventis, is a rapid-acting insulin biosimilar (similar to Novo Nordisk’s Novolog) that helps control blood sugar spikes when taken five to 10 minutes before a meal.
pv-magazine-usa19d
PV Hardware solar trackers and foundations now 100% U.S. made
Solar ground-mount tracker and foundations provider PV Hardware (PVH) announced its U.S.-based manufacturing operations now incorporate 100% U.S.-made components. This makes the company’s products ...
healthday19d
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
WEDNESDAY, Feb. 19, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric ...
U.S. News & World Report19d
FDA Approves First Rapid-Acting Insulin Biosimilar for Patients With Diabetes
The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with diabetes mellitus. Merilog is a ...
Managed Healthcare Executive20d
FDA Approves First Biosimilar of Novolog
Like Novolog, Merilog should be administered within five to 10 minutes before eating. Merilog is administered subcutaneously (under the skin). Merilog is expected to be available on the U.S. market in ...
Interesting Engineering20d
FDA approves first-ever rapid-acting insulin biosimilar for diabetes treatment
The U.S. Food and Drug Administration (FDA) has approved Merilog, a biosimilar to the widely used insulin product Novolog (insulin aspart), to enhance glycemic control in adults and children with ...